v3.25.4
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Dec. 31, 2025
Mar. 31, 2025
Assets    
Cash and cash equivalents $ 2,808 $ 4,052
Finance receivables, net of allowance for credit losses of $463 and $396 54,214 52,516
Investment in operating leases, net 32,458 30,596
Income taxes receivable 430 0
Other assets 1,267 1,270
Derivative instruments 898 389
Total assets 92,171 88,969
Liabilities and Equity    
Debt 65,813 62,547
Income taxes payable 123 505
Deferred income taxes 5,685 5,302
Derivative instruments 719 1,120
Total liabilities 74,053 71,290
Commitments and contingencies (Note 8)
Shareholder’s equity:    
Common stock, $100 par value. Authorized 15,000,000 shares; issued and outstanding 13,660,000 shares as of December 31, 2025 and March 31, 2025 1,366 1,366
Retained earnings 15,773 15,448
Accumulated other comprehensive loss (153) (209)
Total shareholder’s equity 16,986 16,605
Noncontrolling interest in subsidiary 1,132 1,074
Total equity 18,118 17,679
Total liabilities and equity 92,171 88,969
Variable Interest Entity, Primary Beneficiary    
Assets    
Finance receivables, net of allowance for credit losses of $463 and $396 15,190 12,969
Other assets 723 755
Total assets 15,913 13,724
Liabilities and Equity    
Debt 14,433 12,384
Due to Parent and affiliated companies and Other liabilities 25 22
Total liabilities 14,458 12,406
Nonrelated Party and Affiliated Entity    
Liabilities and Equity    
Due to Parent and affiliated companies and Other liabilities 1,569 1,635
Affiliated Entity    
Assets    
Due from Parent and affiliated companies 96 146
Liabilities and Equity    
Due to Parent and affiliated companies and Other liabilities $ 144 $ 181